A detailed history of Assenagon Asset Management S.A. transactions in Boston Scientific Corp stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 3,897,117 shares of BSX stock, worth $352 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
3,897,117
Previous 2,945,537 32.31%
Holding current value
$352 Million
Previous $227 Million 43.97%
% of portfolio
0.68%
Previous 0.58%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$72.96 - $84.0 $69.4 Million - $79.9 Million
951,580 Added 32.31%
3,897,117 $327 Million
Q2 2024

Jul 18, 2024

SELL
$67.33 - $77.71 $9.7 Million - $11.2 Million
-144,116 Reduced 4.66%
2,945,537 $227 Million
Q1 2024

Apr 24, 2024

BUY
$57.6 - $68.62 $59.6 Million - $71 Million
1,034,005 Added 50.3%
3,089,653 $212 Million
Q4 2023

Jan 17, 2024

SELL
$48.64 - $57.81 $58.7 Million - $69.7 Million
-1,205,966 Reduced 36.97%
2,055,648 $119 Million
Q3 2023

Nov 06, 2023

BUY
$50.19 - $54.68 $7.35 Million - $8.01 Million
146,495 Added 4.7%
3,261,614 $172 Million
Q2 2023

Jul 25, 2023

BUY
$49.72 - $54.64 $58.8 Million - $64.6 Million
1,182,680 Added 61.2%
3,115,119 $168 Million
Q1 2023

Apr 18, 2023

SELL
$45.09 - $50.03 $24.1 Million - $26.7 Million
-534,302 Reduced 21.66%
1,932,439 $96.7 Million
Q4 2022

Jan 12, 2023

SELL
$39.56 - $47.22 $51.1 Million - $61 Million
-1,291,963 Reduced 34.37%
2,466,741 $114 Million
Q3 2022

Oct 27, 2022

BUY
$36.71 - $109.66 $23.3 Million - $69.6 Million
635,016 Added 20.33%
3,758,704 $146 Million
Q2 2022

Jul 27, 2022

BUY
$35.24 - $47.1 $1.6 Million - $2.13 Million
45,299 Added 1.47%
3,123,688 $116 Million
Q1 2022

Apr 25, 2022

BUY
$40.9 - $45.1 $43.3 Million - $47.7 Million
1,057,577 Added 52.33%
3,078,389 $136 Million
Q4 2021

Feb 01, 2022

SELL
$38.07 - $44.87 $84.3 Million - $99.4 Million
-2,214,905 Reduced 52.29%
2,020,812 $85.8 Million
Q3 2021

Oct 19, 2021

BUY
$41.23 - $45.88 $30.5 Million - $34 Million
740,282 Added 21.18%
4,235,717 $184 Million
Q2 2021

Jul 15, 2021

BUY
$38.58 - $44.24 $3.92 Million - $4.5 Million
101,710 Added 3.0%
3,495,435 $149 Million
Q1 2021

Apr 26, 2021

SELL
$35.27 - $39.67 $67 Million - $75.4 Million
-1,901,032 Reduced 35.9%
3,393,725 $131 Million
Q4 2020

Feb 01, 2021

BUY
$33.15 - $41.97 $148 Million - $187 Million
4,460,713 Added 534.83%
5,294,757 $190 Million
Q3 2020

Oct 07, 2020

BUY
$34.44 - $42.23 $28.7 Million - $35.2 Million
834,044 New
834,044 $31.9 Million
Q2 2020

Jul 21, 2020

SELL
$30.19 - $39.11 $17.6 Million - $22.8 Million
-583,655 Closed
0 $0
Q1 2020

Apr 17, 2020

SELL
$25.83 - $45.71 $22.6 Million - $39.9 Million
-873,606 Reduced 59.95%
583,655 $19 Million
Q4 2019

Jan 17, 2020

BUY
$37.87 - $45.37 $52.3 Million - $62.6 Million
1,380,055 Added 1787.5%
1,457,261 $65.9 Million
Q3 2019

Oct 16, 2019

SELL
$40.31 - $43.45 $10.6 Million - $11.4 Million
-262,052 Reduced 77.24%
77,206 $3.14 Million
Q2 2019

Aug 12, 2019

SELL
$34.91 - $42.98 $12.3 Million - $15.2 Million
-352,756 Reduced 50.98%
339,258 $14.6 Million
Q1 2019

Apr 26, 2019

BUY
$32.91 - $40.75 $20.3 Million - $25.2 Million
617,226 Added 825.3%
692,014 $26.6 Million
Q4 2018

Jan 23, 2019

BUY
$31.73 - $39.04 $2.02 Million - $2.49 Million
63,682 Added 573.4%
74,788 $2.64 Million
Q3 2018

Oct 29, 2018

SELL
$32.83 - $38.63 $8.17 Million - $9.62 Million
-248,932 Reduced 95.73%
11,106 $428,000
Q2 2018

Jul 17, 2018

SELL
$26.84 - $34.32 $338,828 - $433,255
-12,624 Reduced 4.63%
260,038 $8.5 Million
Q1 2018

Apr 30, 2018

SELL
$25.2 - $28.54 $4.16 Million - $4.71 Million
-164,965 Reduced 37.7%
272,662 $7.45 Million
Q4 2017

Jan 25, 2018

BUY
$24.79 - $29.8 $6.71 Million - $8.06 Million
270,488 Added 161.83%
437,627 $10.8 Million
Q3 2017

Oct 18, 2017

BUY
$26.26 - $29.17 $4.39 Million - $4.88 Million
167,139
167,139 $4.88 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.